What is the recommended ferrous sulfate dosage for treating iron‑deficiency anemia in adults and children?

Recommended Dose of Ferrous Sulfate for Iron-Deficiency Anemia

For adults with iron-deficiency anemia, prescribe 50–100 mg elemental iron once daily (one 200 mg ferrous sulfate tablet containing 65 mg elemental iron), taken on an empty stomach; for children, use 2–3 mg/kg elemental iron once daily. 1

Adult Dosing

The 2024 American Gastroenterological Association and 2021 British Society of Gastroenterology both give a strong recommendation for once-daily dosing rather than multiple daily doses. 1

• Start with one 200 mg ferrous sulfate tablet (65 mg elemental iron) once daily. 2, 1
• Take the tablet on an empty stomach (≥1 hour before or 2 hours after food) to maximize absorption. 1
• A single 60 mg dose of elemental iron raises hepcidin levels that remain elevated for up to 48 hours, blocking further iron absorption during this window—additional doses provide negligible benefit. 1
• Once-daily dosing achieves comparable total iron absorption to twice-daily dosing but significantly reduces gastrointestinal adverse events. 1

If Gastrointestinal Intolerance Occurs

• Switch to alternate-day dosing (one tablet every other day) rather than changing to a different iron salt, which lacks supporting evidence. 2, 1
• Alternate-day regimens delivering 100–200 mg elemental iron provide higher fractional absorption than daily dosing and reduce gastrointestinal side effects by approximately 44% (relative risk 0.56). 2, 1
• Hemoglobin rise may be slower initially, but final hemoglobin increments are comparable after the same cumulative dose. 1, 3
• If the patient cannot tolerate the tablet with food, this modestly reduces absorption but improves compliance. 1

Enhancing Absorption

• Co-administer 80–500 mg vitamin C (ascorbic acid) to enhance non-heme iron absorption. 1
• Avoid tea or coffee within one hour of the dose because polyphenols markedly inhibit iron uptake. 1

Pediatric Dosing

For children aged 9 months to 19 years with iron-deficiency anemia, prescribe 2–3 mg/kg elemental iron once daily. 4, 5

• A 2020 trial in children aged 6–17 months demonstrated that 2 mg/kg daily ferrous sulfate normalized hemoglobin in 95% and ferritin in 84% at 3 months, with high tolerability (only 4.8% experienced drug-related adverse events). 4
• A 2017 randomized trial showed that 3 mg/kg once daily ferrous sulfate was superior to iron polysaccharide complex, increasing hemoglobin by 4.0 g/dL versus 3.4 g/dL over 12 weeks and achieving complete resolution of anemia in 29% versus 6%. 5
• A 2025 meta-analysis of 8,829 children found that low-dose iron (<5 mg/kg/day) combined with treatment durations either <3 months or >6 months optimally improves hemoglobin, particularly in those with lower baseline levels. 6
• For children, always consult a physician for individualized dosing. 7

Monitoring and Treatment Duration

• Check hemoglobin after 2 weeks of therapy; an increase of ≥1 g/dL (10 g/L) indicates an effective response with 90% sensitivity for predicting treatment success. 2, 1
• If the expected rise is absent, consider non-compliance, malabsorption, ongoing blood loss, concurrent vitamin B12 or folate deficiency, or bone marrow pathology. 2
• If no hemoglobin increase occurs after 2 weeks of adherent oral therapy, escalate to intravenous iron. 1
• Monitor hemoglobin every 4 weeks until normalization. 2, 1
• After hemoglobin normalizes, continue oral iron for 2–3 months to replenish iron stores. 2, 1
• Following completion of therapy, re-check a complete blood count every 6 months initially to detect recurrence. 1

When to Switch to Intravenous Iron

Switch to intravenous iron if:

• Intolerance to oral iron persists despite dose reduction (e.g., alternate-day regimen). 1
• No hemoglobin increase after 2 weeks of adherent oral therapy. 2, 1
• Conditions that impair absorption exist (post-bariatric surgery, active inflammatory bowel disease). 1
• Iron losses exceed the capacity of oral absorption (e.g., ongoing heavy bleeding). 2, 1
• Severe symptomatic anemia requires rapid correction. 1

In patients with chronic disease, continuing blood loss, impaired absorption, or gastrointestinal inflammatory pathology, parenteral iron is more effective than continuing traditional oral therapy. 2

Common Pitfalls to Avoid

• Do not prescribe twice- or three-times-daily dosing as first-line; it raises side effects without improving absorption. 1 The FDA label suggesting 2–3 times daily dosing 7 is outdated and contradicts current guideline evidence. 2, 1
• Do not use modified-release iron formulations; they are less effective for oral repletion. 1
• Do not continue ineffective oral therapy indefinitely; reassess at 2 weeks and switch to IV iron if no response. 1
• Do not stop therapy when hemoglobin normalizes; continue for an additional 2–3 months to restore stores. 2, 1
• Do not switch to a different traditional iron salt for intolerance; this practice is not supported by evidence. 2

Side-Effect Profile

• Overall gastrointestinal adverse events occur in 12–31% of patients receiving oral ferrous sulfate: constipation (≈12%), diarrhea (≈8%), nausea (≈11%). 1
• These side effects are dose-dependent and can be mitigated by alternate-day dosing. 1, 3
• A 2020 study found that twice-daily dosing (160 mg elemental iron/day) caused significantly more gastrointestinal side effects than once-daily (80 mg/day) or alternate-day dosing (80 mg every other day), despite similar hemoglobin increases. 3